Vista Pharma Board to Approve Q1 FY27 Results on 14 Aug '26
Vista Pharmaceuticals Ltd 路 Intimation 路 14 Aug 2026, 5:30 am
Vista Pharma Board to Approve Q1 FY27 Results on 14 Aug '26 Vista Pharmaceuticals Ltd (BSE: 524711) has scheduled a Board of Directors meeting for 14 Aug '26. The key agenda item is the consideration and approval of the unaudited financial results for the first quarter ended 30 Jun '26. The board will also review the limited review report for the same period. This meeting will be crucial for assessing the company's performance at the start of the fiscal year.
Original exchange filing (PDF)
More announcements from Vista Pharmaceuticals Ltd
- Resignation of Company Secretary & Compliance Officer 路 12 Sept 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Results for the quarter ended 30.06.2026 路 14 Aug 2026
- Board meeting outcome 路 29 May 2026
- Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited financial .... 路 29 May 2026
- <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> .... 路 29 Apr 2026
- Un audited Financial Results for the quarter ended 31.12.2025 路 13 Feb 2026
- Results for the quarter ended 31.12.2025 路 13 Feb 2026
